Inventor
KINZEL OLAF
DE31 patents
⚠️ This page may combine multiple inventors who share the name “KINZEL OLAF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
6 patentsUS9751874B2Sep 5, 2017
Hydroxy containing FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC35 citations94
US9539244B2Jan 10, 2017
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC28 citations94
US10220027B2Mar 5, 2019
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC10 citations92
US9820979B2Nov 21, 2017
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC16 citations92
US10485795B2Nov 26, 2019
FXR (NR1H4) binding and activity modulating compounds
GILEAD SCIENCES INC10 citations84
US9938278B2Apr 10, 2018
FXR (NR1H4) modulating compounds
GILEAD SCIENCES INC9 citations84
ANGELETTI P IST RICHERCHE BIO
6 patentsUS7414045B2Aug 19, 2008
Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors
ANGELETTI P IST RICHERCHE BIO32 citations92
US7834015B2Nov 16, 2010
Pyrrolo[1,2-a] pyrazin-1(2H)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)
ANGELETTI P IST RICHERCHE BIO20 citations82
US7863294B2Jan 4, 2011
Heterocycle derivatives as histone deacetylase (HDAC) inhibitors
ANGELETTI P IST RICHERCHE BIO5 citations60
US7968553B2Jun 28, 2011
Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
ANGELETTI P IST RICHERCHE BIO0 citations51
US8354413B2Jan 15, 2013
Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
ANGELETTI P IST RICHERCHE BIO0 citations40
US7939537B2May 10, 2011
HIV integrase inhibitors
ANGELETTI P IST RICHERCHE BIO0 citations40
JANSSEN PHARMACEUTICA NV
5 patentsUS9850236B2Dec 26, 2017
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV2 citations71
US10150762B2Dec 11, 2018
Trifluoromethyl alcohols as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US9861618B2Jan 9, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations52
US10080744B2Sep 25, 2018
Thiazoles as modulators of RORγt
JANSSEN PHARMACEUTICA NV0 citations51
US9845319B2Dec 19, 2017
Amide substituted thiazoles as modulators of RORyt
JANSSEN PHARMACEUTICA NV0 citations40
ORSOBIO INC
3 patentsPHENEX PHARMACEUTICALS AG
3 patentsUS9815851B2Nov 14, 2017
Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
PHENEX PHARMACEUTICALS AG1 citations51
US9458104B2Oct 4, 2016
Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ
PHENEX PHARMACEUTICALS AG2 citations51
US10301272B2May 28, 2019
Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]
PHENEX PHARMACEUTICALS AG0 citations41
KINZEL OLAF
2 patentsUS9139539B2Sep 22, 2015
FXR (NR1H4) binding and activity modulating compounds
KINZEL OLAF42 citations95
US8940722B2Jan 27, 2015
Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease
KINZEL OLAF0 citations36